AquaPass

Fluid Overload Treatment Solution

Health Tech & Life Sciences
Active
Seed Tel Aviv-Yafo Founded 2019
Total raised
Last: Seed 2022-01
Stage
Seed
Founded
2019
Headcount
18
HQ
Tel Aviv-Yafo
Sector
Health Tech & Life Sciences

About

AquaPass is an early-stage medical device startup aiming to revolutionize the treatment of fluid overload. Its noninvasive, drug-free fluid overload treatment system removes fluids directly from the interstitial compartment through the skin by controlling and enhancing the natural process of perspiration.

The company’s award-winning, patented system is composed of a wearable body suit with a microclimate generator designed to create the optimal environmental conditions to induce both natural perspiration and its immediate evaporation, ensuring that the patient remains dry and free of thermal discomfort.

The AquaPass system maintains a stable core temperature while enabling treatment to be optimized according to each patient’s individual physiology. This highly efficient and safe treatment can be provided in the hospital, at outpatient clinics, and at home.

Funding history · 2 rounds · — total

2022-01
Seed Undisclosed
2019-07
Undisclosed Undisclosed

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is AquaPass's primary focus as a medical device startup?
AquaPass is an early-stage medical device startup focused on revolutionizing the treatment of fluid overload through a noninvasive, drug-free system.
When was AquaPass founded?
AquaPass was founded in July 2019.
What is the core technology behind AquaPass's fluid overload treatment system?
AquaPass's system uses a patented, wearable body suit with a microclimate generator to induce and evaporate natural perspiration, removing fluids from the interstitial compartment through the skin.
Where is AquaPass headquartered?
AquaPass is headquartered in Tel Aviv-Yafo, Israel.
Has AquaPass secured any funding rounds?
AquaPass has secured an undisclosed round in July 2019 with BRM Group and a Seed round in January 2022 with Arbelon Holdings Ltd. For full financing history, refer to startupim.
What is AquaPass's current product development stage?
AquaPass's product is currently in the clinical trial stage.
How many employees does AquaPass currently have?
AquaPass currently has 18 employees.
Who is a co-founder of AquaPass?
Yaacov Nitzan is a co-founder of AquaPass.
Does AquaPass hold any patents for its technology?
Yes, AquaPass holds one patent for its technology.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B

Highlights

1 Patents

Tags

wearablewearabletreatmentsmedical-devices